Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Ascent Pediatrics

This article was originally published in The Tan Sheet

Executive Summary

Ascent Pediatrics: Files NDA Dec. 30 for Feverall extended-release acetaminophen for children. The pediatric analgesic is designed to be given every eight hours, compared to current acetaminophen products, which are administered every four hours. The clinical data in the NDA extends to children as young as two years. Wilmington, Mass.-based Ascent introduced three pediatric products in November: Feverall acetaminophen suppositories, Pediamist nasal saline spray and Just for Kids multivitamin drops ("The Tan Sheet" Oct. 20, 1997, p. 4)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087945

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel